Health Canada is warning consumers that the supposedly herbal product 'POWER-MAX' has been found to contain sildenafil, Media release 09 February 2013 Pages: 2 - 2
Roche and Biogen Idec have suspended trials of ocrelizumab treatment in patients with rheumatoid arthritis due to safety concerns, Media release 09 February 2013 Pages: 2 - 2
A homozygous UGT1A1*28 genotype appears to predict grade 3−4 treatment-induced neutropenia in patients receiving irinotecan, Clinical study 09 February 2013 Pages: 3 - 3